Laddar...
Treatment of high-risk neuroblastoma
Although high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT) have improved the prognosis for patients with high-risk neuroblastoma (NB), event-free survival rates remain in the range of 30 to 40%, which is unsatisfactory. To further improve outcomes, several clinical trial...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Korean Pediatric Society
2012-04-01
|
| Serie: | Korean Journal of Pediatrics |
| Ämnen: | |
| Länkar: | http://kjp.or.kr/upload/pdf/kjped-55-115.pdf |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|